Biotechnology
Swiss companies operating in the same biotechnology industry
The list below has Swiss companies that operate under the same industry, biotechnology. The list helps track their performance, income statement, and more. Sorted by any necessary metric, it can show the most expensive stocks of the industry such as LONZA N or those with the best price dynamics like GILEAD SCIENCES, thus assisting in designing strategies of any focus.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AMGAMGEN INC | 145.72 B CHF | 268.622 CHF | −3.51% | 10 | 1.49 | 39.18 | 6.86 CHF | −34.77% | 3.03% | Health technology | Buy |
 GISGILEAD SCIENCES | 109.49 B CHF | 93.005 CHF | +3.33% | 64 | 0.41 | 276.10 | 0.34 CHF | −91.12% | 3.20% | Health technology | Buy |
 LO3LONZA GROUP AG | 42.81 B CHF | 596.613 CHF | −2.21% | 220 | 1.38 | 66.88 | 8.92 CHF | +0.50% | 0.66% | Health technology | Strong buy |
| LONNLONZA N | 42.81 B CHF | 598.6 CHF | −1.68% | 197.57 K | 0.93 | 67.11 | 8.92 CHF | +0.50% | 0.66% | Health technology | Strong buy |
| LONNELONZA N 2. LINIE | 42.81 B CHF | 597.2 CHF | −2.23% | 7.6 K | 1.01 | 66.95 | 8.92 CHF | +0.50% | 0.66% | Health technology | — |
 22UABIONTECH SEDR | 25.08 B CHF | 104.399 CHF | −3.33% | 422 | 3.61 | — | −1.83 CHF | −117.32% | 0.00% | Health technology | Buy |
 0QFMODERNA INC | 10.88 B CHF | 27.828 CHF | −2.76% | 1.01 K | 11.50 | — | −4.94 CHF | +42.26% | 0.00% | Health technology | Neutral |
 1CGCRISPR THERAPEUTIC | 3.09 B CHF | 36.096 CHF | +0.34% | 70 | 0.47 | — | −3.96 CHF | −138.55% | 0.00% | Health technology | Buy |
 38IINTELLIA THERAPEUT | 857.17 M CHF | 8.938 CHF | −35.38% | 20 | 0.22 | — | −4.61 CHF | +5.83% | 0.00% | Health technology | Buy |
 YTSNKUROS BIOSCIENCES | 809.07 M CHF | 22.117 CHF | +0.29% | 350 | 0.78 | — | −0.24 CHF | +46.76% | 0.00% | Health technology | Strong buy |
| KURNKUROS N | 809.07 M CHF | 22.35 CHF | −0.45% | 50.25 K | 0.57 | — | −0.24 CHF | +46.76% | 0.00% | Health technology | Strong buy |
 PPGNPOLYPEPTIDE N | 731.64 M CHF | 22.00 CHF | −0.68% | 26.67 K | 1.03 | — | −0.83 CHF | +24.38% | 0.00% | Health technology | Neutral |
 5CVCUREVAC NV | 725.6 M CHF | 3.290 CHF | −3.83% | 56 | 0.06 | 7.15 | 0.46 CHF | — | 0.00% | Health technology | Buy |
 MOLNMOLECULAR PARTNERS N | 177.04 M CHF | 4.375 CHF | −0.23% | 5.84 K | 0.35 | — | −1.90 CHF | −6.91% | 0.00% | Health technology | Buy |
| 6MLMOLECULAR PARTNERS | 177.04 M CHF | 4.427 CHF | −10.82% | 450 | 1.58 | — | −1.90 CHF | −6.91% | 0.00% | Health technology | Buy |
 1S9SERES THERAPEUTICS | 124.66 M CHF | 0.751 CHF | −4.94% | 5.5 K | 0.95 | — | −1.01 CHF | +2.45% | 0.00% | Health technology | Buy |
 4XBXBIOTECH INC | 91.92 M CHF | 3.040 CHF | −19.94% | 1.5 K | 1.64 | — | −0.91 CHF | −30.67% | 0.00% | Health technology | — |
| BBIOVBIOVERSYS N | — | 34.000 CHF | +1.19% | 6.79 K | — | — | — | — | — | Health technology | — |